The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    BLACKPINK Jennie's 'Solo' music video hits record high 900 mil. YouTube views

  • 3

    Japanese students' field trips to Korea resume after pandemic hiatus

  • 5

    Lotte desperate to win LVMH Chairman Arnault's heart

  • 7

    President Yoon refutes criticism of fence-mending summit with Japan

  • 9

    Apple Pay service starts in Korea

  • 11

    US report voices concerns over S. Korea's press freedom

  • 13

    Busan to have alternate no-driving days during Expo inspection

  • 15

    Korean firms balk at donating to fund compensating victims of Japan's forced labor

  • 17

    Osstem Implant to invite 1,500 dentists from 22 countries for training

  • 19

    VIDEOMiracle rescue of 200 dogs caged for dog meat

  • 2

    Lee Se-young to lead MBC's new series 'The Story of Park's Marriage Contract'

  • 4

    Possibly next SOHO, Seoul selects 5 neighborhoods for new signature 'K-alleys'

  • 6

    Kakao criticized for half-baked AI chatbot

  • 8

    INTERVIEW'The Flag': Kwon Jin-ah's love letter to people chasing their dreams

  • 10

    Kwon Sang-woo's new series to stream on Disney+ this year

  • 12

    LVMH allegedly joins takeover bid to acquire Missha

  • 14

    Revenge rises as key theme in K-dramas

  • 16

    Shinhan, Woori shine in overseas business

  • 18

    Korean startup Innospace announces successful test launch of space vehicle HANBIT-TLV

  • 20

    MZ generation-led unions flex muscle across board

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Thu, March 23, 2023 | 10:16
POSCO International to expand carbon capture biz in green energy push
POSCO International to expand carbon capture biz in green energy push
POSCO International said Tuesday it will nurture carbon capture and storage (CCS) as one of its future growth drivers as the trading company accelerates its expansion into green energy.
2023-03-21 11:32
Samsung Biologics seeks to expand partnerships in New York
Samsung Biologics seeks to expand partnerships in New York
Samsung Biologics will take part in 2023 DCAT Week, a global event in the bio and pharmaceutical industry, which will take place in New York from March 20 to 23, in a bid to seek more partnerships, the company said Thursday. Hosted by the Drug, Chemical & Associated Technologies Association (DCAT), DCAT Week has been a representative networking event in the pharmaceutical ind...
Baek Byung-yeul | 2023-03-16 16:05
Celltrion founder to return to management after 2 year-hiatus
Celltrion founder to return to management after 2 year-hiatus
Seo Jung-jin, founder and honorary chairman of Celltrion, may return to management after two years, on expectations he can save the biotechnology group that is facing growing business uncertainties, according to company officials, Friday.
Baek Byung-yeul | 2023-03-03 16:52
Kakao Healthcare to launch blood sugar managing app in Q3
Kakao Healthcare to launch blood sugar managing app in Q3
Kakao Healthcare, a subsidiary of internet company Kakao, revealed a detailed vision for digital healthcare, saying it will launch a blood sugar management app in the third quarter of this year, according to the CEO, Thursday. “Digital healthcare has emerged as a lucrative business,” Hwang Hee, CEO of Kakao Healthcare, said during a press conference at Kakao's building in Seo...
Baek Byung-yeul | 2023-03-02 16:22
Samsung Biologics hit by series of attempts to steal trade secrets
Samsung Biologics hit by series of attempts to steal trade secrets
Samsung Biologics has been grappling with a series of attempts to steal its trade secrets as competition is intensifying in contract-based drug development and manufacturing, according to police and industry officials, Monday. Incheon Metropolitan Police said one of Samsung Biologics' employees was arrested recently for attempting to take company data from a worksite without ...
Baek Byung-yeul | 2023-02-27 16:56
Will Medytox's legal win over Daewoong deal blow to Hugel?
Will Medytox's legal win over Daewoong deal blow to Hugel?
Medytox's legal win over Daewoong Pharmaceutical is expected to shake up the local botulinum toxin (BTX) market, as Medytox, Korea's first Botox developer, is also embroiled in a legal tussle with another competitor, Hugel in the United States, over the BTX strain used to manufacture the cosmetics treatment, according to the companies, Monday. On Friday, the Seoul District Co...
Baek Byung-yeul | 2023-02-13 16:45
Medytox wins botulinum toxin patent suit against Daewoong
Medytox wins botulinum toxin patent suit against Daewoong
Medytox won a lawsuit against Daewoong Pharmaceutical on Friday over a botulinum toxin (BTX or Botox) patent. The two companies had locked horns over the origin of BTX strain used to manufacture the cosmetic treatment. “Daewoong Pharmaceutical's Nabota was developed by stealing Medytox's botulinum toxin strains and manufacturing process,” the Seoul Central District Court said...
Baek Byung-yeul | 2023-02-12 16:29
HLB's anticancer drug wins approval in China
HLB's anticancer drug wins approval in China
HLB's anticancer drug Rivoceranib was approved to be used for first-line treatment for liver cancer in China, the Korean biotech company said Thursday. The company said China's National Medical Products Administration (NMPA) approved the combination therapy of Rivoceranib and Camrelizumab, an anticancer drug of China's Jiangsu Hengrui Medicine, as a first-line treatment for l...
Baek Byung-yeul | 2023-02-02 16:44
SK Bioscience recruits experts for global expansion
SK Bioscience recruits experts for global expansion
SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch,...
Baek Byung-yeul | 2023-01-20 14:40
Korea to invest $222.9 million in bio RD projects in 2023
Korea to invest $222.9 million in bio RD projects in 2023
Korea will extend 274.6 billion won ($222.9 million) for research and development in the bio industry this year, the industry ministry said Friday.
2023-01-20 10:35
 1 2345678
Top 10 Stories
1Korean firms balk at donating to fund compensating victims of Japan's forced laborKorean firms balk at donating to fund compensating victims of Japan's forced labor
2Sexual assaults by Korean diplomats continue despite zero-tolerance policy Sexual assaults by Korean diplomats continue despite zero-tolerance policy
3Main opposition leader indicted, faces calls to resignMain opposition leader indicted, faces calls to resign
4Consumers choose to travel abroad over purchasing luxury goods Consumers choose to travel abroad over purchasing luxury goods
5World water day World water day
6Outback Steakhouse sees sales soar as it opens stores in large shopping malls Outback Steakhouse sees sales soar as it opens stores in large shopping malls
7Samsung, SK avoid worst-case scenario as US 'guardrails' are less stringent than feared Samsung, SK avoid worst-case scenario as US 'guardrails' are less stringent than feared
8Korean pension fund hit by overseas banking crisis Korean pension fund hit by overseas banking crisis
9[INTERVIEW] Retired FSC chief finds inspiration exploring Koreans' ancestral roots INTERVIEWRetired FSC chief finds inspiration exploring Koreans' ancestral roots
10Campaign launched to promote equal treatment for multicultural families Campaign launched to promote equal treatment for multicultural families
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group